Brief: Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP
26/06/2026 12:16
BRIEF-Daybu® (Trofinetide) Recommended For Approval In The European Union By CHMP June 26 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O:
DAYBU® (TROFINETIDE) RECOMMENDED FOR APPROVAL IN THE EUROPEAN UNION BY CHMP
ACADIA PHARMACEUTICALS - EUROPEAN COMMISSION DECISION ON DAYBU EXPECTED IN COMING MONTHS
ACADIA PHARMACEUTICALS - DAYBU MARKETING AUTHORIZATION WOULD COVER EU, ICELAND, LIECHTENSTEIN, NORWAY IF APPROVED
Source text: ID:nBw7Y5MF9a
Further company coverage: ACAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry